DEPLOYDatabase

Robot model

Sentire

surgicalpilotby Cornerstone Robotics

Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology.

Track Sentire
Manufacturer
Cornerstone Robotics
Form factor
surgical
Maturity
pilot
Lifecycle
active
Deployments
2

The verified answer

As of Oct 2026, DEPLOY verifies Sentire, a surgical by Cornerstone Robotics (pilot): 2 verified deployments on record. 2 sources back the record.

Overview

Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.

Verified vs. claimed

Maturity stage
pilot(Small-scale deployment in controlled or trial conditions.)
Sources on file
View all sources →

Key facts

Clearance

EU CE Mark MDR + Singapore HSA (May 2026)

Specialties

General surgery, gynecology, thoracic, urology

CE Mark MDR approval May 2026 (company PR)

Cornerstone Robotics announced on May 25, 2026 that the Sentire Endoscopic Surgical System received EU CE mark certification under the Medical Device Regulation (MDR) for minimally invasive procedures in general surgery, gynecology, thoracic, and urology (PR Newswire / Cornerstone Robotics).

UK clinical investigation and market approvals framing (company PR)

Cornerstone Robotics stated Sentire completed multi-specialty clinical investigation work with Portsmouth Hospitals University NHS Trust and that the system has market approval across China, the European Union, and Singapore. Treat clinical outcome claims as company-stated (PR Newswire / Cornerstone Robotics).

Data & sources

Web sources

2

2 sources backing this record.View all →

Pricing

No verified price is on record for Sentire. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

  • Sentire at Hong Kongpilot

    Cornerstone Robotics, Hong Kong-based surgical robotics innovator, presenting at 2nd Global Health Summit 2026.

  • Sentire at Shenzhenoperational

    Cornerstone Robotics 100th surgical robot rolled off Shenzhen production line in 2025.

Free to use on your site, with a link back to DEPLOY.

Sentire on the deployment map

View the global map

Where Sentire is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Sentire.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://www.prnewswire.com/news-releases/sentire-surgical-system-receives-ce-mark-mdr-approval-cornerstone-robotics-enters-a-new-era-in-its-global-expansion-302780965.html
  2. https://en.csrbtx.com/press-release/57

Common questions

What is Sentire?
Endoscopic surgical robotic system CE-marked under EU MDR in May 2026, covering general surgery, gynecology, thoracic, and urology. Clinical investigation ongoing at Portsmouth Hospitals NHS Trust; no FDA 510(k) filed for U.S. market.
How much does Sentire cost?
Sentire's price is not publicly disclosed. DEPLOY has no verified price on record for Sentire from Cornerstone Robotics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Sentire actually deployed in the real world?
Yes. Sentire is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Sentire?
Sentire is made by Cornerstone Robotics, based in Hong Kong, founded in 2019.
Where is Sentire deployed?
2 verified deployments of Sentire are on the DEPLOY registry, including at Hong Kong, Shenzhen.
Can you buy Sentire?
Sentire is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Sentire?
On the DEPLOY registry, comparable surgical robots to Sentire include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.
How does Sentire compare to da Vinci (and Ion)?
Sentire and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Sentire has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Sentire a top surgical?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Sentire ranks in roughly the top 17% of surgical models tracked by the registry.
What is Sentire's maturity stage?
Sentire is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Sentire safe?
Sentire has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-09-29

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-09-29

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: surgical

Sources by quality tier

2
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Sentire.

Recent coverage

Sentire in third-party press

Medtronic invests $700M in surgical partner Cornerstone Robotics

Sep 3, 2026

Cornerstone Robotics Partners with Medtronic to Expand Robotic Surgery Access

Sep 3, 2026

Medtronic Makes $700 Million Investment In Cornerstone Robotics Partnership To Expand Robotic-Assisted Surgery

Sep 2, 2026